At the same time, the NGF and NTRK1 receptor form a previously unknown important autocrine epithelial survival axis in HNSCC, which might be active in cell survival mechanisms following chemotherapeutic treatments of DNA crosslinking agents as cisplatin or MMC. The gene discussed is NGF; the disease is head and neck squamous cell carcinoma.